On Wednesday, Novavax, Inc. (NASDAQ:NVAX) agreed to sell its Bohumil, Czech Republic manufacturing facility to Novo Nordisk A/S (NYSE:NVO) for $200 million. The agreement includes transferring assets, including a 150,000-square-foot recombinant protein manufacturing facility with support buildings, the existing workforce, and all related and required infrastructure. Also Read: FDA Gives Green Signal To Novavax’s COVID-19-Influenza Combo Vaccine …

Benzinga

New York

United States

Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million - Novo Nordisk (NYSE:NVO), Novavax (NASDAQ:NVAX)

Ad Fontes Media

Media Bias/Fact Check

The American pharmaceutical company Novavax has signed an agreement to sell its plant in the Czech Republic to the Danish company Novo Nordisk for 200 million dollars (4.8 billion crowns). She made the announcement in a press release today.

Americká farmaceutická společnost Novavax podepsala smlouvu o prodeji svého závodu v České republice dánské firmě Novo Nordisk za 200 milionů dolarů (4,8 miliardy korun). Oznámila to dnes v tiskové zprávě.

Novavax prodává svůj závod v Česku za 200 milionů dolarů firmě Novo Nordisk - Seznam Zprávy

seznamzpravy.cz

Novavax sells its plant in the Czech Republic for $200 million to Novo Nordisk

Novo Nordisk works at high pressure to keep up with the demand for the company's products, including the weight loss agent Wegovy. It is probably in this light that the pharmaceutical giant's acquisition of ...

Novo Nordisk arbejder på højtryk for at kunne følge med efterspørgslen på selskabets produkter, herunder vægttabsmidlet Wegovy. Det er formentlig i det lys, at man skal se medicinalgigantens opkøb af ...

Novo Nordisk køber fabrik i Tjekkiet

Jyllands-Posten

Aarhus

Denmark

Novo Nordisk buys a factory in the Czech Republic

Danish Novo Nordisk - the world's leading manufacturer of insulin and weight loss preparations - has agreed to buy a medicine factory in Bohumil, Czech Republic, for 200 million dollars (equivalent to 2.2 billion kroner).

Danska Novo Nordisk – världsledande tillverkare av insulin och viktminskningspreparat – har gjort upp om att köpa en medicinfabrik i Bohumil, Tjeckien, för 200 miljoner dollar (motsvarande 2,2 miljarder kronor).

Novo Nordisk köper fabrik

Expressen

Bonnier Group

Stockholm

Stockholm County

Sweden

Novo Nordisk buys factory

Novo Nordisk buys factory for DKK 1.4 billion. Over recent years, Novo Nordisk has repeatedly invested billions in increasing its production capacity, and now the company is doing it again: Thus, Novo N

Novo Nordisk køber fabrik for 1,4 mia. kr.Over de seneste år har Novo Nordisk ad flere omgange investeret milliarder i at øge sin produktionsevne, og nu gør virksomheden det igen: Således køber Novo N

Novo Nordisk køber fabrik for 1,4 mia. kr.

borsen.dk

Novo Nordisk buys factory for DKK 1.4 billion. DKK

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.

BizToc

Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln

Things were looking up for Novavax stock after the FDA resolved a clinical hold. But the company trimmed its outlook. Is NVAX stock a sell? The post Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell? appeared first on Investor's Business Daily.

All Sides

Investor's Business Daily

Novavax Cut Its Outlook Despite Beating Forecasts. Is It A Sell?

Novo Nordisk, the Danish company that makes diabetes drug Ozempic and obesity treatment Wegovy, has begun work on a 5.3ha quality control centre in Hillerød, about 20km north of Copenhagen.  
The facility will cost €390m to build, the largest investment the company has made in advanced quality control.  
The company needs the centre to manage its new products and fast-expanding manufacturing capacity, said Erik Lorin Rasmussen, head of product s…

globalconstructionreview.com

Wegovy-maker Novo Nordisk to build €390m quality control centre - Global Construction Review

New York - The American pharmaceutical company Novavax has signed an agreement to sell its plant in the Czech Republic to the Danish company Novo Nordisk for USD 200 million (CZK 4.8 billion). She announced this in a press release. Novavax bought a factory in the village of Bohumil near Jevan in Central Bohemia in 2020.

New York - Americká farmaceutická společnost Novavax podepsala smlouvu o prodeji svého závodu v České republice dánské firmě Novo Nordisk za 200 milionů USD (4,8 miliardy Kč). Oznámila to v tiskové zprávě. Novavax koupil továrnu v obci Bohumil nedaleko středočeských Jevan v roce 2020.

Novavax prodává svůj závod v Česku za 200 milionů USD firmě Novo Nordisk | ČeskéNoviny.cz

ceskenoviny.cz

Novavax sells its plant in the Czech Republic for USD 200 million to Novo Nordisk CzechNoviny.cz

(Reuters) - COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline. The company has struggled to keep pace with rival vaccine makers Moderna and Pfizer, which reported more

Wegovy Maker Novo Nordisk To Buy Novavax's Czech Republic Manufacturing Facility For $200 Million - Novo Nordisk (NYSE:NVO), Novavax (NASDAQ:NVAX)

Coverage Details

Give the gift of Perspective

Bias Distribution

Ownership

Similar News Topics

Similar News Topics